Table 1.
Demographic and functional parameters in ILD patients and controls.
| ILD | ||||||
| CONTROLS (N = 11) | TOTAL (N = 49)♦ | IPF (N = 23) | LAM (N = 15) | CHP (N = 6) | CLF (5) | |
| Age years (SD) | 65 (9) | 60 (12)* | 68 (9) | 47 (7) | 63 (11) | 58 (11) |
| Sex (M / F) | 9 / 2 | 24 / 25 | 17/6 | 0/15 | 2/4 | 4/1 |
| Ex‐ smokers | 0 / 11 | 19 / 49 | 15/23 | 3/15 | 4/6 | 1/5 |
| FVC % (SD) | 103 (11) | 76 (16)† | 72 (24) | 89 (13) | 70 (22) | 74 (18) |
| FEV1 % (SD) | 106 (11) | 75 (18)† | 79 (26) | 71 (24) | 76 (21) | 81 (19) |
| TLC % (SD) | 98 (11) | 80 (19)† | 74 (26) | 98 (13) | 72 (17) | 73 (19) |
| DLco % (SD) | 103 (21) | 46 (16)† | 39 (16) | 55 (18) | 46 (12) | 56 (12) |
ILD – interstitial lung disease; IPF – interstitial pulmonary fibrosis; LAM – lymphangioleiomyomatosis; CHP – chronic hypersensitivity pneumonitis; CLF – centrilobular fibrosis; SD ‐ Standard deviation; FVC % ‐ predicted forced vital capacity; FEV1 % ‐ predicted forced expiratory volume in the first second; TLC % ‐ predicted total lung capacity; DLco % ‐ predicted diffusion capacity for carbon monoxide
♦
t test between controls and all 49 ILD patients
*
p value not significant †p < 0,05